Clinical Trial Update: Proteomic Study of Tears From Patients With a PAX6 Mutation [NA]

View source ↗

Summary

Completed clinical trial studying the tear proteome of patients with PAX6 mutation (aniridia) to better understand disease biology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aniridia

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Aniridia | NA | Status: COMPLETED